BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Gammagard Liquid 10%: Completed Phase III enrollment

Baxter completed enrollment of 390 AD patients ages 50-89 in a double-blind, placebo-controlled, U.S. and Canadian Phase III trial evaluating 200 and 400 mg/kg IV Gammagard Liquid 10% every 2 weeks for...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >